Common Variation at 12q24.13 (OAS3) Influences Chronic Lymphocytic Leukemia Risk

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2014 Nov 4

PMID 25363670

Citations 17

Authors

G P Sava

H E Speedy

M C Di Bernardo

M J S Dyer

A Holroyd

N J Sunter

H Marr

L Mansouri

S Deaglio

L Karabon

I Frydecka

K Jamroziak

D Woszczyk

G Juliusson

K E Smedby

S Jayne

A Majid

Y Wang

C Dearden

A G Hall

T Mainou-Fowler

G H Jackson

G Summerfield

R J Harris

A R Pettitt

D J Allsup

J R Bailey

G Pratt

C Pepper

C Fegan

R Rosenquist

D Catovsky

J M Allan

R S Houlston

Affiliations

Soon will be listed here.

Citing Articles

CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia.

Galasso M, Salaorni V, Moia R, Mozzo V, Lovato E, Cosentino C Hematol Oncol. 2024; 42(6):e70002.

PMID: 39540258 PMC: 11590045. DOI: 10.1002/hon.70002.

Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer.

Gao L, Ren R, Shen J, Hou J, Ning J, Feng Y BMC Cancer. 2022; 22(1):1016.

PMID: 36162993 PMC: 9510761. DOI: 10.1186/s12885-022-10102-8.

Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review.

Ribeiro Junior H, Novaes L, Datorre J, Moreno D, Reis R Curr Oncol. 2022; 29(8):5517-5530.

PMID: 36005174 PMC: 9406904. DOI: 10.3390/curroncol29080436.

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia.

Kolijn P, Muggen A, Ljungstrom V, Agathangelidis A, Wolvers-Tettero I, Beverloo H Front Oncol. 2021; 11:740083.

PMID: 34513715 PMC: 8427434. DOI: 10.3389/fonc.2021.740083.

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans.

Kleinstern G, Weinberg J, Parikh S, Braggio E, Achenbach S, Robinson D Leukemia. 2021; 36(1):119-125.

PMID: 34285341 PMC: 8727288. DOI: 10.1038/s41375-021-01344-9.

References

Sellick G, Catovsky D, Houlston R . Familial chronic lymphocytic leukemia. Semin Oncol. 2006; 33(2):195-201. DOI: 10.1053/j.seminoncol.2006.01.013. View

Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B . The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2010; 117(2):563-74. PMC: 3031480. DOI: 10.1182/blood-2010-05-284984. View

Zhao Y, Kang H, Ji Y, Chen X . Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis. Clin Exp Med. 2012; 13(3):171-6. PMC: 7088208. DOI: 10.1007/s10238-012-0193-6. View

Speedy H, Di Bernardo M, Sava G, Dyer M, Holroyd A, Wang Y . A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2013; 46(1):56-60. DOI: 10.1038/ng.2843. View

Slager S, Rabe K, Achenbach S, Vachon C, Goldin L, Strom S . Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2010; 117(6):1911-6. PMC: 3056639. DOI: 10.1182/blood-2010-09-308205. View

Di Bernardo M, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R . A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008; 40(10):1204-10. DOI: 10.1038/ng.219. View

Power C, Elliott J . Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol. 2005; 35(1):34-41. DOI: 10.1093/ije/dyi183. View

Lim J, Lisco A, McDermott D, Huynh L, Ward J, Johnson B . Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009; 5(2):e1000321. PMC: 2642680. DOI: 10.1371/journal.ppat.1000321. View

Berndt S, Skibola C, Joseph V, Camp N, Nieters A, Wang Z . Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013; 45(8):868-76. PMC: 3729927. DOI: 10.1038/ng.2652. View

10.

Bonnevie-Nielsen V, Field L, Lu S, Zheng D, Li M, Martensen P . Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet. 2005; 76(4):623-33. PMC: 1199299. DOI: 10.1086/429391. View

11.

Crowther-Swanepoel D, Broderick P, Di Bernardo M, Dobbins S, Torres M, Mansouri M . Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet. 2010; 42(2):132-6. PMC: 5321238. DOI: 10.1038/ng.510. View

12.

Slager S, Skibola C, Di Bernardo M, Conde L, Broderick P, McDonnell S . Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood. 2012; 120(4):843-6. PMC: 3412347. DOI: 10.1182/blood-2012-03-413591. View

13.

Naik S, Paranjape J, Silverman R . RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates. Nucleic Acids Res. 1998; 26(6):1522-7. PMC: 147421. DOI: 10.1093/nar/26.6.1522. View

14.

Penegar S, Wood W, Lubbe S, Chandler I, Broderick P, Papaemmanuil E . National study of colorectal cancer genetics. Br J Cancer. 2007; 97(9):1305-9. PMC: 2360468. DOI: 10.1038/sj.bjc.6603997. View

15.

Noguchi S, Hamano E, Matsushita I, Hijikata M, Ito H, Nagase T . Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells. Hum Immunol. 2012; 74(3):395-401. PMC: 7115495. DOI: 10.1016/j.humimm.2012.11.011. View